Resources
FACT SHEET – In vitro mast cells
Unlock the potential of mast cell research with Genoskin’s In Vitro Human Mast Cell Services for Drug Development.
CASE STUDY – Cetrorelix & ISR
Discover how the ImmunoSafe: ISR Platform® support the evaluation of local immune reactions caused by subcutaneous administration of Cetrorelix.
APPLICATION NOTE – ISR
Explore how the ISR Platform® can effectively de-risk your injectable therapeutic candidates today!
APPLICATION NOTE – Non clinical toxicity services
Discover a quick approach to de-risk your injectable therapeutic candidates using ex vivo live human skin.
APPLICATION NOTE – InflammaSkin® studies for topical therapeutics
Explore InflammaSkin®, a unique T cell-driven skin inflammation platform to test your topical anti-psoriasis formulas.
APPLICATION NOTE – InflammaSkin® studies for injectable therapeutics
Uncover InflammaSkin®, a unique T cell-driven skin inflammation platform to test your injecatble anti-psoriasis formulas.
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
SUBSCRIBE TO GENOSKIN’S NEWSLETTER
CONTACT INFO EUROPE
31100 Toulouse, France
CONTACT INFO USA
Salem, MA 01970, USA
